David L. McGlasson

1.4k total citations
41 papers, 1.0k citations indexed

About

David L. McGlasson is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, David L. McGlasson has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Cardiology and Cardiovascular Medicine and 8 papers in Physiology. Recurrent topics in David L. McGlasson's work include Venous Thromboembolism Diagnosis and Management (7 papers), Heparin-Induced Thrombocytopenia and Thrombosis (6 papers) and Clinical Laboratory Practices and Quality Control (6 papers). David L. McGlasson is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (7 papers), Heparin-Induced Thrombocytopenia and Thrombosis (6 papers) and Clinical Laboratory Practices and Quality Control (6 papers). David L. McGlasson collaborates with scholars based in United States and Italy. David L. McGlasson's co-authors include George A. Fritsma, Robin L. Brey, Gary Gronseth, A. Escalante, Stephen L. Holliday, Inmaculada del Rincón, Marta Navarrete, Amy R. Saklad, Dirk M. Elston and Anneke C. Bush and has published in prestigious journals such as Blood, Neurology and Stroke.

In The Last Decade

David L. McGlasson

39 papers receiving 975 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David L. McGlasson United States	13	491	210	189	184	152	41	1.0k
Junzo Nojima Japan	19	526 1.1×	82 0.4×	229 1.2×	415 2.3×	88 0.6×	55	1.1k
Gabriela Medina Mexico	24	757 1.5×	124 0.6×	482 2.6×	184 1.0×	165 1.1×	83	1.7k
Henrique Luiz Staub Brazil	17	497 1.0×	42 0.2×	203 1.1×	226 1.2×	75 0.5×	77	845
Stefan M. Weiner Germany	21	495 1.0×	226 1.1×	223 1.2×	73 0.4×	59 0.4×	56	1.4k
Jean‐Philippe Defour Belgium	15	177 0.4×	78 0.4×	169 0.9×	467 2.5×	60 0.4×	29	1.4k
P Madoz Spain	18	68 0.1×	120 0.6×	117 0.6×	308 1.7×	95 0.6×	48	1.2k
Folke D. Lindström Sweden	19	297 0.6×	55 0.3×	345 1.8×	266 1.4×	124 0.8×	55	1.5k
Anne Ricksten Sweden	21	263 0.5×	46 0.2×	201 1.1×	122 0.7×	120 0.8×	59	1.7k
R G Lahita United States	15	687 1.4×	47 0.2×	562 3.0×	77 0.4×	133 0.9×	20	1.3k
Michael A. Catalano United States	13	132 0.3×	28 0.1×	346 1.8×	66 0.4×	44 0.3×	45	1.0k

Countries citing papers authored by David L. McGlasson

Since Specialization

Citations

This map shows the geographic impact of David L. McGlasson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. McGlasson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. McGlasson more than expected).

Fields of papers citing papers by David L. McGlasson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. McGlasson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. McGlasson. The network helps show where David L. McGlasson may publish in the future.

Co-authorship network of co-authors of David L. McGlasson

This figure shows the co-authorship network connecting the top 25 collaborators of David L. McGlasson. A scholar is included among the top collaborators of David L. McGlasson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. McGlasson. David L. McGlasson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fritsma, George A., et al.. (2018). Labeling tubes before collection threatens patient safety. Annals of Blood. 3. 16–16. 2 indexed citations

Fritsma, George A. & David L. McGlasson. (2017). Whole Blood Platelet Aggregometry. Methods in molecular biology. 1646. 333–347. 24 indexed citations

McGlasson, David L. & George A. Fritsma. (2015). Measuring dabigatran with the dilute Russell viper venom confirm assay in an anticoagulation clinic population. Blood Coagulation & Fibrinolysis. 27(1). 53–57. 6 indexed citations

McGlasson, David L., Anand Shah, & George A. Fritsma. (2011). Ability of the INNOVANCE PFA P2Y system to detect clopidogrel-induced ADP receptor blockade in preangiocath individuals. Blood Coagulation & Fibrinolysis. 22(7). 583–587. 2 indexed citations

McGlasson, David L.. (2011). Career Research Opportunities for the Medical Laboratory Scientist. American Society for Clinical Laboratory Science. 24(3). 130–135. 1 indexed citations

Lin, Pei-Chun, Samuel O. Jones, & David L. McGlasson. (2010). Effects of Glucosamine and Celadrin on Platelet Function. American Society for Clinical Laboratory Science. 23(1). 32–36. 5 indexed citations

McGlasson, David L., et al.. (2009). Duration of Loxosceles reclusa venom detection by ELISA from swabs.. PubMed. 22(4). 216–22. 12 indexed citations

McGlasson, David L. & George A. Fritsma. (2009). Whole Blood Platelet Aggregometry and Platelet Function Testing. Seminars in Thrombosis and Hemostasis. 35(2). 168–180. 76 indexed citations

Dick, Edward J., et al.. (2009). Evaluation of four hematology and a chemistry portable benchtop analyzers using non‐human primate blood. Journal of Medical Primatology. 38(6). 390–396. 5 indexed citations

10.

McGlasson, David L., et al.. (2008). Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy. Blood Coagulation & Fibrinolysis. 19(6). 513–517. 19 indexed citations

11.

McGlasson, David L., et al.. (2005). Effects of pre-analytical variables on the anti-activated factor X chromogenic assay when monitoring unfractionated heparin and low molecular weight heparin anticoagulation. Blood Coagulation & Fibrinolysis. 16(3). 173–176. 21 indexed citations

12.

McGlasson, David L. & Patrick N. Shaklee. (2004). A Multi-Instrument Evaluation of a Commercial Chromogenic Factor X Assay To Monitor Oral Anticoagulation Therapy.. Blood. 104(11). 4059–4059. 2 indexed citations

13.

Brey, Robin L., Stephen L. Holliday, Amy R. Saklad, et al.. (2002). Neuropsychiatric syndromes in lupus. Neurology. 58(8). 1214–1220. 434 indexed citations

14.

McGlasson, David L., et al.. (1999). Drawing specimens for coagulation testing: is a second tube necessary?. PubMed. 12(3). 137–9. 11 indexed citations

15.

Brey, Robin L., et al.. (1994). Effects of Repeated Freeze–Thaw Cycles on Anticardiolipin Antibody Immunoreactivity. American Journal of Clinical Pathology. 102(5). 586–588. 22 indexed citations

16.

Rusnak, Janice M., Clifford A. Butzin, David L. McGlasson, & Stephen P. Blatt. (1994). False-Positive Rapid Plasma Reagin Tests in Human Immunodeficiency Virus Infection and Relationship to Anti-Cardiolipin Antibody and Serum Immunoglobulin Levels. The Journal of Infectious Diseases. 169(6). 1356–1359. 30 indexed citations

17.

Wilson, Michael R., et al.. (1993). Serum Endotoxin, Tumor Necrosis Factor, and Interleukin-6 Response to Total Hip Arthroplasty. Military Medicine. 158(11). 712–716. 9 indexed citations

18.

McGlasson, David L., et al.. (1993). Aggregation of killer whale platelets. Thrombosis Research. 70(3). 225–231. 10 indexed citations

19.

Lucey, Daniel R., Craig W. Hendrix, Chester Andrzejewski, et al.. (1990). Hepatitis C Antibody in a Non-Hemophiliac Cohort Infected with the Human Immunodeficiency Virus. Viral Immunology. 3(4). 295–301. 3 indexed citations

20.

McGlasson, David L., et al.. (1988). Evaluation of Three Modified Ivy Bleeding Time Devices. Laboratory Medicine. 19(10). 645–648. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact